OBJECTIE: To ealuate the efficacy, safety and tolerability of daily doses of 25, 50, and 100 mg of zonisamide (ZNS) administered as adjunctie treatment in patients with Parkinson disease (PD).
OBJECTIE: To ealuate the efficacy, safety and tolerability of daily doses of 25, 50, and 100 mg of zonisamide (ZNS) administered as adjunctie treatment in patients with Parkinson disease (PD).
目的：评估唑尼沙胺(ZNS)每日服用不同剂量（25，50以及100毫克）作为帕金森病（PD）辅助治疗的有效性，安全性以及耐受性。